These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 172473)

  • 21. Transcription of Epstein-Barr virus genomes in human lymphoblastoid cells and in somatic-cell hybrids of Burkitt's lymphoma.
    Nonoyama M; Tanaka A; Silver S; Glaser R
    IARC Sci Publ (1971); 1978; (24 Pt 1):559-63. PubMed ID: 221360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of Epstein-Barr virus in hybrid cells.
    Tsang KY; Hann WD
    J Natl Cancer Inst; 1977 May; 58(5):1295-301. PubMed ID: 192898
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Somatic cell hybrids between human lymphoma cell lines. V. IdUrd inducibility and P3HR-1 superinfectability of Daudi/HeLa (DAD) and Daudi/P3HR-1 (DIP-1) cell lines.
    Moar MH; Ber R; Klein G; Westman A; Eriksson I
    Int J Cancer; 1978 Dec; 22(6):669-74. PubMed ID: 82545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell surface markers on epithelial-Burkitt hybrid cells superinfected with Epstein-Barr virus.
    Glaser R; Lenoir G; Ferrone S; Pellegrino MA; de-Thé G
    Cancer Res; 1977 Jul; 37(7 Pt 1):2291-6. PubMed ID: 193641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Study on the effect of human herpesvirus 6 on replication of Epstein-Barr virus].
    Xia Q; Meng G; Ai Y
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1998 Aug; 33(4):235-6. PubMed ID: 11717892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. B cell phenotype-dependent expression of the Epstein-Barr virus nuclear antigens EBNA-2 to EBNA-6: studies with somatic cell hybrids.
    Contreras-Brodin BA; Anvret M; Imreh S; Altiok E; Klein G; Masucci MG
    J Gen Virol; 1991 Dec; 72 ( Pt 12)():3025-33. PubMed ID: 1662694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of the Epstein-Barr virus genome by 5-aza-cytidine in latently infected human lymphoid lines.
    Ben-Sasson SA; Klein G
    Int J Cancer; 1981 Aug; 28(2):131-5. PubMed ID: 6172387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Partial elimination of latent Epstein-Barr virus genomes from virus-producing cells by cyclohexamide.
    Tanaka A; Nonoyama M; Hampar B
    Virology; 1976 Mar; 70(1):164-70. PubMed ID: 176800
    [No Abstract]   [Full Text] [Related]  

  • 29. Enhancement of spontaneous VCA and EA induction in B95-8 cells and EA induction in Raji cells treated with human leukocyte interferon.
    Zeng Y; Zhong JM; de Thé G; Wu SH; Hou YT; Miao XQ
    Intervirology; 1982; 18(1-2):33-7. PubMed ID: 6181009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transforming activity of Epstein-Barr virus obtained by superinfection of Raji cells.
    Yajima Y; Marczynska B; Nonoyama M
    Proc Natl Acad Sci U S A; 1978 Apr; 75(4):2008-10. PubMed ID: 205877
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Expression of an Epstein-Barr virus early antigen and cell fusion].
    Furukawa M; Kamide M; Kato C; Sakashita H; Takeshita H; Umeda R
    Nihon Jibiinkoka Gakkai Kaiho; 1989 May; 92(5):722-5. PubMed ID: 2559176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of latent Epstein-Barr virus genomes in human epithelial/Burkitt's lymphoblastoid hybrid cells.
    Nonoyama M; Tanaka A; Glaser R
    IARC Sci Publ (1971); 1978; (20):397-402. PubMed ID: 215523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of Epstein-Barr virus early antigen by phytohaemagglutinin in the presence of 5-iodo-2'-deoxyuridine: application to EBV serology.
    Lenoir G; Tovey MG; Lavoue MF
    J Immunol Methods; 1980; 34(1):23-9. PubMed ID: 6252264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amounts of Epstein-Barr virus DNA in somatic cell hybrids between burkitt lymphoma-derived cell lines.
    Andersson M
    J Virol; 1975 Nov; 16(5):1345-7. PubMed ID: 171457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of n-butyrate on Epstein-Barr virus-carrying lymphoma lines.
    Anisimová E; Saemundsen AK; Roubal J; Vonka V; Klein G
    J Gen Virol; 1982 Jan; 58 Pt 1():163-71. PubMed ID: 6292341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation by the polyoxotungstate HPA-23 of Epstein-Barr virus early antigen expression in Raji cells treated with iododeoxyuridine.
    Souyri-Caporale M; Tovey MG; Ono K; Jasmin C; Chermann JC
    J Gen Virol; 1984 Apr; 65 ( Pt 4)():831-5. PubMed ID: 6323625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Time of synthesis and cellular location of Epstein-Barr virus-specified polypeptides radioimmunoprecipitated from iododeoxyuridine-induced Burkitt lymphoma/somatic cell hybrids.
    Durnford JM; Scanlon PA; Glaser R
    J Gen Virol; 1982 May; 60(Pt 1):39-48. PubMed ID: 6284867
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of indomethacin on Epstein-Barr virus early antigen induction.
    Daniel LW; Bauer G; zur Hausen H
    Cancer Res; 1984 Mar; 44(3):981-3. PubMed ID: 6318991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The spontaneous and induced synthesis of Epstein-Barr virus antigens in Raji cells immobilized on surface coated with anti-lymphocyte globulin.
    Bayliss GJ; Wolf H
    J Gen Virol; 1981 Jun; 54(Pt 2):397-401. PubMed ID: 6270256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Superinfection of epithelial hybrid cells (D98/HR-1, NPC-KT, and A2L/AH) with Epstein-Barr virus and the relationship to the C3d receptor.
    Takimoto T; Sato H; Ogura H; Miyawaki T; Glaser R
    Cancer Res; 1986 May; 46(5):2541-4. PubMed ID: 3008992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.